Muscular Dystrophy Association Announces Gene Therapy Support Network for Families Living with Neuromuscular Disease
New York, May 22, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) announced today the launch of the MDA Gene Therapy Support Network (GTx) , ahead of a pending FDA approval for the first gene therapy for Duchenne muscular dystrophy (DMD).
- New York, May 22, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) announced today the launch of the MDA Gene Therapy Support Network (GTx) , ahead of a pending FDA approval for the first gene therapy for Duchenne muscular dystrophy (DMD).
- The expanded nationally renowned MDA Resource Center offers nationwide one-on-one expert support and guidance for newly approved gene therapy treatments for people living with neuromuscular diseases (NMDs).
- In addition, MDA GTx will provide gene therapy resources and educational opportunities for families to inform their decision-making process.
- “The Gene Therapy Support Network and the advances it represents are more than 70 years in the making; MDA pioneered the genetic research that has brought us to this exciting moment in time for families impacted by neuromuscular disease.